Heads Up: Abbvie's Migraine Portfolio 'Very, Very Strong'
Heads Up: Abbvie's Migraine Portfolio 'Very, Very Strong' - 06/13/2024
Source: mediapost.com
Stay updated with breaking news from Dawn Buse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Heads Up: Abbvie's Migraine Portfolio 'Very, Very Strong' - 06/13/2024
Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. However, with new treatments on the market during the past few years and research continuing at a record pace, patients and their providers may be able to find an optimal treatment plan.